LMT vs ORMP
Lockheed Martin Corporation (LMT) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported LMT revenue for 2025-12-31 was $75.05B. Net income was $5.02B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
LMT currently screens at market cap $108.37B and trailing P/E 19.9. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the LMT and ORMP stock pages for the full models.
Not investment advice.